Analyst Gena Wang works at BARCLAYS and is focused on the Healthcare sector with 495 price targets and ratings documented since 2015 spanning on 35 stocks. Previously, Gena Wang worked at JEFFERIES. Analyst's average stock valuation to be materialised ratio is 62.49% with an average time for price targets to be met of 172.35 days.
Most recent stock forecast was given on SGEN, Seattle Genetics, Inc at 14-Mar-2023.
Gena Wang best performing recommendations are on SGTX (SIGILON THERAPEUTICS INC).
The best stock recommendation documented was for SGTX (SIGILON THERAPEUTICS INC) at 12/29/2020. The price target of $48 was fulfilled within 2 days with a profit of $10.6 (28.34%) receiving and performance score of 141.71.
Average potential price target upside
Currently, out of the existing stock ratings of Gena Wang - 19678 which are a Buy (67.25%), 6083 which are a Hold (20.79%), 3501 which are a Sell (11.96%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
415
$225.02 (118.44%)
415
24 days ago
1/5 (20%)
$132.63 (72.68%)
664
Buy
240
$50.02 (26.33%)
240
1 months 3 days ago
9/10 (90%)
$24.7 (15.49%)
199
Buy
249
$59.02 (31.07%)
256
1 months 3 days ago
12/14 (85.71%)
$31.46 (20.49%)
139
Buy
304
$114.02 (60.02%)
304
1 months 3 days ago
6/8 (75%)
$40.31 (32.66%)
421
Buy
250
$60.02 (31.59%)
250
1 months 3 days ago
9/11 (81.82%)
$43.49 (48.18%)
396
